Related Experiment Video

Updated: Jun 21, 2026

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases
03:22

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases

Published on: March 1, 2024

Empiric antibiotic selection for infectious emergencies: bacterial pneumonia, meningitis and sepsis

E Paul O'Donnell1, Kristin M Hurt, Marc H Scheetz

  • 1Northwestern Memorial Hospital, Department of Pharmacy, Chicago, Illinois 60611, USA. eodonnel@nmh.org

Drugs of Today (Barcelona, Spain : 1998)
|July 9, 2009
PubMed

Insights

Prompt empiric antibiotic therapy for severe bacterial infections like pneumonia, meningitis, and sepsis is crucial for reducing mortality. Clinicians must consider pathogens, resistance patterns, and patient factors while avoiding broad-spectrum overuse and de-escalating therapy when possible.

Area of Science:

  • Infectious Diseases
  • Clinical Microbiology
  • Pharmacology

Background:

  • Early management of infectious emergencies is critical for patient outcomes.
  • Failure to administer appropriate empiric antibiotics increases mortality risk.
  • Knowledge of common pathogens, resistance patterns, and patient factors guides effective treatment.

Purpose of the Study:

  • To review common bacterial pathogens and empiric antibiotic recommendations for severe infections in immunocompetent adults.
  • To discuss factors influencing antibiotic selection in acute-care settings.
  • To emphasize appropriate use and de-escalation of antibiotic therapy.

Main Methods:

  • Review of literature on bacterial pneumonia, meningitis, and sepsis.
  • Discussion of common pathogens and antibiotic susceptibility patterns.
  • Analysis of patient-specific risk factors and regional resistance data.

Main Results:

  • Empiric antibiotic choice requires understanding disease state, common pathogens, and patient risk factors.
  • Regional and institutional antibiotic resistance patterns are essential considerations.
  • Avoiding broad-spectrum antibiotics and de-escalating therapy are key to antimicrobial stewardship.

Conclusions:

  • Appropriate empiric antibiotic selection and administration are vital for managing severe bacterial infections.
  • Consideration of local resistance patterns and patient factors optimizes treatment.
  • Antimicrobial stewardship principles, including de-escalation, are essential for preventing resistance.

More Related Videos

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: